News

The Impact Journals news page hosts content about important news articles and press releases from our Journals and Editorial Board Members.

News

Mission
The Impact Journals news page hosts articles about important news stories from our journals and within the scientific community. Visit this page for the latest in medical advances, pharmaceutical progress, conference reports, and more.

Aging | Downregulation of senescence-associated secretory phenotype by knockdown of secreted frizzled-related protein 4 contributes to the prevention of skin aging

Aging

October 31, 2022
PRESS RELEASE: A new research paper was published on the cover of Aging's Volume 14, Issue 20, entitled, “Downregulation of senescence-associated secretory phenotype by knockdown of secreted frizzled-related protein 4 contributes to the prevention of skin aging.” continue reading »

Oncotarget is Again on MEDLINE

News

October 27, 2022
PRESS RELEASE: On September 15, 2022, Oncotarget was accepted again for indexing by MEDLINE. Oncotarget is now indexed by MEDLINE/PubMed and PubMed Central/PubMed. continue reading »

Aging | RNA modifications in aging-associated cardiovascular diseases

News

October 26, 2022
PRESS RELEASE: A new review paper was published in Aging's Volume 14, Issue 19, entitled, “RNA modifications in aging-associated cardiovascular diseases.” continue reading »

Oncotarget | Therapeutic efficacy of the humanized JAA-F11 anti-Thomsen-Friedenreich antibody constructs H2aL2a and H3L3 in human breast and lung cancer xenograft models

News

October 25, 2022
PRESS RELEASE: On October 19, 2022, a new research paper was published in Oncotarget, entitled, “Therapeutic efficacy of the humanized JAA-F11 anti-Thomsen-Friedenreich antibody constructs H2aL2a and H3L3 in human breast and lung cancer xenograft models.” continue reading »

Oncotarget | Platelet-derived growth factor (PDGF) cross-signaling via non-corresponding receptors indicates bypassed signaling in colorectal cancer

News

October 20, 2022
PRESS RELEASE: On October 19, 2022, a new research paper was published in Oncotarget, entitled, “Platelet-derived growth factor (PDGF) cross-signaling via non-corresponding receptors indicates bypassed signaling in colorectal cancer.” continue reading »